Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271

1.

Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study.

Robbin ML, Greene T, Allon M, Dember LM, Imrey PB, Cheung AK, Himmelfarb J, Huber TS, Kaufman JS, Radeva MK, Roy-Chaudhury P, Shiu YT, Vazquez MA, Umphrey HR, Alexander L, Abts C, Beck GJ, Kusek JW, Feldman HI; Hemodialysis Fistula Maturation Study Group.

J Am Soc Nephrol. 2018 Oct 11. pii: ASN.2017111225. doi: 10.1681/ASN.2017111225. [Epub ahead of print]

PMID:
30309898
2.

Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip.

Sakolish C, Weber EJ, Kelly EJ, Himmelfarb J, Mouneimne R, Grimm FA, House JS, Wade T, Han A, Chiu WA, Rusyn I.

Sci Rep. 2018 Oct 5;8(1):14882. doi: 10.1038/s41598-018-33099-2.

3.

Kidneys on Chips: Emerging Technology for Preclinical Drug Development.

Yeung CK, Himmelfarb J.

Clin J Am Soc Nephrol. 2018 Oct 1. pii: CJN.06690518. doi: 10.2215/CJN.06690518. [Epub ahead of print] No abstract available.

PMID:
30274990
4.

Human Organ-Specific Endothelial Cell Heterogeneity.

Marcu R, Choi YJ, Xue J, Fortin CL, Wang Y, Nagao RJ, Xu J, MacDonald JW, Bammler TK, Murry CE, Muczynski K, Stevens KR, Himmelfarb J, Schwartz SM, Zheng Y.

iScience. 2018 Jun 29;4:20-35. doi: 10.1016/j.isci.2018.05.003. Epub 2018 May 9.

5.

Chronic kidney disease attenuates the plasma metabolome response to insulin.

Roshanravan B, Zelnick LR, Djucovic D, Gu H, Alvarez JA, Ziegler TR, Gamboa JL, Utzschneider K, Kestenbaum B, Himmelfarb J, Kahn SE, Raftery D, de Boer IH.

JCI Insight. 2018 Aug 23;3(16). pii: 122219. doi: 10.1172/jci.insight.122219. [Epub ahead of print]

6.

Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Wang K, Zelnick LR, Imrey PB, deBoer IH, Himmelfarb J, Allon MD, Cheung AK, Dember LM, Roy-Chaudhury P, Vazquez MA, Kusek JW, Feldman HI, Beck GJ, Kestenbaum B; the Hemodialysis Fistula Maturation Study Group.

Am J Nephrol. 2018;48(1):56-64. doi: 10.1159/000491828. Epub 2018 Aug 2.

PMID:
30071516
7.

Alteration of HDL Protein Composition with Hemodialysis Initiation.

Wang K, Zelnick LR, Hoofnagle AN, Vaisar T, Henderson CM, Imrey PB, Robinson-Cohen C, de Boer IH, Shiu YT, Himmelfarb J, Beck GJ, Kestenbaum B; HFM Study.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1225-1233. doi: 10.2215/CJN.11321017. Epub 2018 Jul 25.

PMID:
30045914
8.

Reevaluating the role of megalin in renal vitamin D homeostasis using a human cell-derived microphysiological system.

Chapron BD, Chapron A, Phillips B, Okoli MC, Shen DD, Kelly EJ, Himmelfarb J, Thummel KE.

ALTEX. 2018 Jul 8. doi: 10.14573/altex.1803161. [Epub ahead of print]

9.

Novel PAradigm to improve Inflammatory burden in end stage Renal disease (rePAIR): study protocol for a randomized controlled trial.

Trivedi R, Fares G, Nunez VB, Campbell R, Clement M, Burleson J, Himmelfarb J, Ioannidou E.

Trials. 2018 Jul 11;19(1):370. doi: 10.1186/s13063-018-2760-y.

10.

Bioelectrical Impedance Analysis Measures and Clinical Outcomes in CKD.

Bansal N, Zelnick LR, Himmelfarb J, Chertow GM.

Am J Kidney Dis. 2018 Jun 6. pii: S0272-6386(18)30643-7. doi: 10.1053/j.ajkd.2018.03.030. [Epub ahead of print]

PMID:
29885923
11.

GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.

Tuegel C, Katz R, Alam M, Bhat Z, Bellovich K, de Boer I, Brosius F, Gadegbeku C, Gipson D, Hawkins J, Himmelfarb J, Ju W, Kestenbaum B, Kretzler M, Robinson-Cohen C, Steigerwalt S, Bansal N.

Am J Kidney Dis. 2018 Oct;72(4):519-528. doi: 10.1053/j.ajkd.2018.03.025. Epub 2018 Jun 14.

PMID:
29866459
12.

High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping.

Czerniecki SM, Cruz NM, Harder JL, Menon R, Annis J, Otto EA, Gulieva RE, Islas LV, Kim YK, Tran LM, Martins TJ, Pippin JW, Fu H, Kretzler M, Shankland SJ, Himmelfarb J, Moon RT, Paragas N, Freedman BS.

Cell Stem Cell. 2018 Jun 1;22(6):929-940.e4. doi: 10.1016/j.stem.2018.04.022. Epub 2018 May 17.

PMID:
29779890
13.

A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis.

Miller CP, Tsuchida C, Zheng Y, Himmelfarb J, Akilesh S.

Neoplasia. 2018 Jun;20(6):610-620. doi: 10.1016/j.neo.2018.02.011. Epub 2018 May 7.

14.

Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study.

Allon M, Imrey PB, Cheung AK, Radeva M, Alpers CE, Beck GJ, Dember LM, Farber A, Greene T, Himmelfarb J, Huber TS, Kaufman JS, Kusek JW, Roy-Chaudhury P, Robbin ML, Vazquez MA, Feldman HI; Hemodialysis Fistula Maturation (HFM) Study Group.

Am J Kidney Dis. 2018 May;71(5):677-689. doi: 10.1053/j.ajkd.2017.10.027. Epub 2018 Feb 2.

PMID:
29398178
15.

Weekly Standard Kt/Vurea and Clinical Outcomes in Home and In-Center Hemodialysis.

Rivara MB, Ravel V, Streja E, Obi Y, Soohoo M, Cheung AK, Himmelfarb J, Kalantar-Zadeh K, Mehrotra R.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):445-455. doi: 10.2215/CJN.05680517. Epub 2018 Jan 11.

PMID:
29326306
16.

Perioperative THR-184 and AKI after Cardiac Surgery.

Himmelfarb J, Chertow GM, McCullough PA, Mesana T, Shaw AD, Sundt TM, Brown C, Cortville D, Dagenais F, de Varennes B, Fontes M, Rossert J, Tardif JC.

J Am Soc Nephrol. 2018 Feb;29(2):670-679. doi: 10.1681/ASN.2017020217. Epub 2017 Dec 4.

PMID:
29203473
17.

Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.

Chang SY, Weber EJ, Sidorenko VS, Chapron A, Yeung CK, Gao C, Mao Q, Shen D, Wang J, Rosenquist TA, Dickman KG, Neumann T, Grollman AP, Kelly EJ, Himmelfarb J, Eaton DL.

JCI Insight. 2017 Nov 16;2(22). pii: 95978. doi: 10.1172/jci.insight.95978. [Epub ahead of print]

18.

Acute Kidney Injury and Risk of Incident Heart Failure Among US Veterans.

Bansal N, Matheny ME, Greevy RA Jr, Eden SK, Perkins AM, Parr SK, Fly J, Abdel-Kader K, Himmelfarb J, Hung AM, Speroff T, Ikizler TA, Siew ED.

Am J Kidney Dis. 2018 Feb;71(2):236-245. doi: 10.1053/j.ajkd.2017.08.027. Epub 2017 Nov 20.

PMID:
29162339
19.

Clinical Genetic Testing for APOL1: Are we There Yet?

Young BA, Fullerton SM, Wilson JG, Cavanaugh K, Blacksher E, Spigner C, Himmelfarb J, Burke W.

Semin Nephrol. 2017 Nov;37(6):552-557. doi: 10.1016/j.semnephrol.2017.07.009. Review.

PMID:
29110763
20.

Concise Review: Current and Emerging Biomarkers of Nephrotoxicity.

Weber EJ, Himmelfarb J, Kelly EJ.

Curr Opin Toxicol. 2017 Jun;4:16-21. doi: 10.1016/j.cotox.2017.03.002. Epub 2017 Apr 12.

21.

Metabolic Effects of Diet and Exercise in Patients with Moderate to Severe CKD: A Randomized Clinical Trial.

Ikizler TA, Robinson-Cohen C, Ellis C, Headley SAE, Tuttle K, Wood RJ, Evans EE, Milch CM, Moody KA, Germain M, Limkunakul C, Bian A, Stewart TG, Himmelfarb J.

J Am Soc Nephrol. 2018 Jan;29(1):250-259. doi: 10.1681/ASN.2017010020. Epub 2017 Oct 16.

PMID:
29038285
22.

Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease.

Cruz NM, Song X, Czerniecki SM, Gulieva RE, Churchill AJ, Kim YK, Winston K, Tran LM, Diaz MA, Fu H, Finn LS, Pei Y, Himmelfarb J, Freedman BS.

Nat Mater. 2017 Nov;16(11):1112-1119. doi: 10.1038/nmat4994. Epub 2017 Oct 2.

23.

Circulating levels of soluble Fas (sCD95) are associated with risk for development of a nonresolving acute kidney injury subphenotype.

Bhatraju PK, Robinson-Cohen C, Mikacenic C, Harju-Baker S, Dmyterko V, Slivinski NSJ, Liles WC, Himmelfarb J, Heckbert SR, Wurfel MM.

Crit Care. 2017 Aug 17;21(1):217. doi: 10.1186/s13054-017-1807-x.

24.

Kidney function is associated with an altered protein composition of high-density lipoprotein.

Rubinow KB, Henderson CM, Robinson-Cohen C, Himmelfarb J, de Boer IH, Vaisar T, Kestenbaum B, Hoofnagle AN.

Kidney Int. 2017 Dec;92(6):1526-1535. doi: 10.1016/j.kint.2017.05.020. Epub 2017 Jul 26.

PMID:
28754556
25.

Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.

Alpers CE, Imrey PB, Hudkins KL, Wietecha TA, Radeva M, Allon M, Cheung AK, Dember LM, Roy-Chaudhury P, Shiu YT, Terry CM, Farber A, Beck GJ, Feldman HI, Kusek JW, Himmelfarb J; Hemodialysis Fistula Maturation Study Group.

J Am Soc Nephrol. 2017 Oct;28(10):3076-3088. doi: 10.1681/ASN.2016050598. Epub 2017 Jul 19.

26.

Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study.

Cheung AK, Imrey PB, Alpers CE, Robbin ML, Radeva M, Larive B, Shiu YT, Allon M, Dember LM, Greene T, Himmelfarb J, Roy-Chaudhury P, Terry CM, Vazquez MA, Kusek JW, Feldman HI; Hemodialysis Fistula Maturation Study Group.

J Am Soc Nephrol. 2017 Oct;28(10):3005-3013. doi: 10.1681/ASN.2016121355. Epub 2017 Jul 14.

27.

Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis.

Chapron A, Shen DD, Kestenbaum BR, Robinson-Cohen C, Himmelfarb J, Yeung CK.

Clin Transl Sci. 2017 Sep;10(5):395-403. doi: 10.1111/cts.12481. Epub 2017 Jul 4.

28.

Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.

Cardenas-Gonzalez M, Srivastava A, Pavkovic M, Bijol V, Rennke HG, Stillman IE, Zhang X, Parikh S, Rovin BH, Afkarian M, de Boer IH, Himmelfarb J, Waikar SS, Vaidya VS.

Clin Chem. 2017 Sep;63(9):1515-1526. doi: 10.1373/clinchem.2017.274175. Epub 2017 Jun 30.

29.

A Two-Biomarker Model Predicts Mortality in the Critically Ill with Sepsis.

Mikacenic C, Price BL, Harju-Baker S, O'Mahony DS, Robinson-Cohen C, Radella F, Hahn WO, Katz R, Christiani DC, Himmelfarb J, Liles WC, Wurfel MM.

Am J Respir Crit Care Med. 2017 Oct 15;196(8):1004-1011. doi: 10.1164/rccm.201611-2307OC.

30.

Global Cardiovascular and Renal Outcomes of Reduced GFR.

Thomas B, Matsushita K, Abate KH, Al-Aly Z, Ärnlöv J, Asayama K, Atkins R, Badawi A, Ballew SH, Banerjee A, Barregård L, Barrett-Connor E, Basu S, Bello AK, Bensenor I, Bergstrom J, Bikbov B, Blosser C, Brenner H, Carrero JJ, Chadban S, Cirillo M, Cortinovis M, Courville K, Dandona L, Dandona R, Estep K, Fernandes J, Fischer F, Fox C, Gansevoort RT, Gona PN, Gutierrez OM, Hamidi S, Hanson SW, Himmelfarb J, Jassal SK, Jee SH, Jha V, Jimenez-Corona A, Jonas JB, Kengne AP, Khader Y, Khang YH, Kim YJ, Klein B, Klein R, Kokubo Y, Kolte D, Lee K, Levey AS, Li Y, Lotufo P, El Razek HMA, Mendoza W, Metoki H, Mok Y, Muraki I, Muntner PM, Noda H, Ohkubo T, Ortiz A, Perico N, Polkinghorne K, Al-Radaddi R, Remuzzi G, Roth G, Rothenbacher D, Satoh M, Saum KU, Sawhney M, Schöttker B, Shankar A, Shlipak M, Silva DAS, Toyoshima H, Ukwaja K, Umesawa M, Vollset SE, Warnock DG, Werdecker A, Yamagishi K, Yano Y, Yonemoto N, Zaki MES, Naghavi M, Forouzanfar MH, Murray CJL, Coresh J, Vos T; Global Burden of Disease 2013 GFR Collaborators; CKD Prognosis Consortium; Global Burden of Disease Genitourinary Expert Group.

J Am Soc Nephrol. 2017 Jul;28(7):2167-2179. doi: 10.1681/ASN.2016050562. Epub 2017 Apr 13.

31.

Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study.

van Ballegooijen AJ, Zelnick L, Hoofnagle AN, Hamburg NM, Robinson-Cohen C, Roy-Chaudhury P, Cheung AK, Shiu YT, de Boer IH, Himmelfarb J, Beck G, Imrey PB, Kusek JW, Kestenbaum B; Hemodialysis Fistula Maturation (HFM) Study Group.

Am J Kidney Dis. 2017 Jun;69(6):805-814. doi: 10.1053/j.ajkd.2017.01.049. Epub 2017 Mar 27.

32.

Corrigendum: Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle.

Vernetti L, Gough A, Baetz N, Blutt S, Broughman JR, Brown JA, Foulke-Abel J, Hasan N, In J, Kelly E, Kovbasnjuk O, Repper J, Senutovitch N, Stabb J, Yeung C, Zachos NC, Donowitz M, Estes M, Himmelfarb J, Truskey G, Wikswo JP, Taylor DL.

Sci Rep. 2017 Mar 16;7:44517. doi: 10.1038/srep44517. No abstract available.

33.

Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle.

Vernetti L, Gough A, Baetz N, Blutt S, Broughman JR, Brown JA, Foulke-Abel J, Hasan N, In J, Kelly E, Kovbasnjuk O, Repper J, Senutovitch N, Stabb J, Yeung C, Zachos NC, Donowitz M, Estes M, Himmelfarb J, Truskey G, Wikswo JP, Taylor DL.

Sci Rep. 2017 Feb 8;7:42296. doi: 10.1038/srep42296. Erratum in: Sci Rep. 2017 Mar 16;7:44517.

34.

Growth Differentiation Factor-15 and Risk of CKD Progression.

Nair V, Robinson-Cohen C, Smith MR, Bellovich KA, Bhat ZY, Bobadilla M, Brosius F, de Boer IH, Essioux L, Formentini I, Gadegbeku CA, Gipson D, Hawkins J, Himmelfarb J, Kestenbaum B, Kretzler M, Magnone MC, Perumal K, Steigerwalt S, Ju W, Bansal N.

J Am Soc Nephrol. 2017 Jul;28(7):2233-2240. doi: 10.1681/ASN.2016080919. Epub 2017 Feb 3.

35.

Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial.

Rivara MB, Yeung CK, Robinson-Cohen C, Phillips BR, Ruzinski J, Rock D, Linke L, Shen DD, Ikizler TA, Himmelfarb J.

Am J Kidney Dis. 2017 Mar;69(3):389-399. doi: 10.1053/j.ajkd.2016.08.041. Epub 2016 Dec 4.

36.

The CKD Classification System in the Precision Medicine Era.

Hall YN, Himmelfarb J.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):346-348. doi: 10.2215/CJN.09310916. Epub 2016 Nov 30. No abstract available.

37.

Physical activity and metabolic health in chronic kidney disease: a cross-sectional study.

Bowlby W, Zelnick LR, Henry C, Himmelfarb J, Kahn SE, Kestenbaum B, Robinson-Cohen C, Utzschneider KM, de Boer IH.

BMC Nephrol. 2016 Nov 22;17(1):187.

38.

Acute kidney injury subphenotypes based on creatinine trajectory identifies patients at increased risk of death.

Bhatraju PK, Mukherjee P, Robinson-Cohen C, O'Keefe GE, Frank AJ, Christie JD, Meyer NJ, Liu KD, Matthay MA, Calfee CS, Christiani DC, Himmelfarb J, Wurfel MM.

Crit Care. 2016 Nov 17;20(1):372.

39.

Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study.

Liu KD, Siew ED, Reeves WB, Himmelfarb J, Go AS, Hsu CY, Bennett MR, Devarajan P, Ikizler TA, Kaufman JS, Kimmel PL, Chinchilli VM, Parikh CR; ASSESS-AKI Study Investigators.

PLoS One. 2016 Oct 27;11(10):e0164832. doi: 10.1371/journal.pone.0164832. eCollection 2016.

40.

Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics.

Prasad B, Johnson K, Billington S, Lee C, Chung GW, Brown CD, Kelly EJ, Himmelfarb J, Unadkat JD.

Drug Metab Dispos. 2016 Dec;44(12):1920-1924. Epub 2016 Sep 12.

41.

Decellularized Human Kidney Cortex Hydrogels Enhance Kidney Microvascular Endothelial Cell Maturation and Quiescence.

Nagao RJ, Xu J, Luo P, Xue J, Wang Y, Kotha S, Zeng W, Fu X, Himmelfarb J, Zheng Y.

Tissue Eng Part A. 2016 Oct;22(19-20):1140-1150. Epub 2016 Aug 30.

42.

Indication for Dialysis Initiation and Mortality in Patients With Chronic Kidney Failure: A Retrospective Cohort Study.

Rivara MB, Chen CH, Nair A, Cobb D, Himmelfarb J, Mehrotra R.

Am J Kidney Dis. 2017 Jan;69(1):41-50. doi: 10.1053/j.ajkd.2016.06.024.

43.

Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.

Rivara MB, Adams SV, Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Katz R, Molnar MZ, Ravel V, Soohoo M, Streja E, Himmelfarb J, Mehrotra R.

Kidney Int. 2016 Dec;90(6):1312-1320. doi: 10.1016/j.kint.2016.06.028. Epub 2016 Aug 20.

44.

Development of a microphysiological model of human kidney proximal tubule function.

Weber EJ, Chapron A, Chapron BD, Voellinger JL, Lidberg KA, Yeung CK, Wang Z, Yamaura Y, Hailey DW, Neumann T, Shen DD, Thummel KE, Muczynski KA, Himmelfarb J, Kelly EJ.

Kidney Int. 2016 Sep;90(3):627-37. doi: 10.1016/j.kint.2016.06.011.

45.

Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients.

Robinson-Cohen C, Newitt R, Shen DD, Rettie AE, Kestenbaum BR, Himmelfarb J, Yeung CK.

PLoS One. 2016 Aug 11;11(8):e0161074. doi: 10.1371/journal.pone.0161074. eCollection 2016.

46.

Vascular Function at Baseline in the Hemodialysis Fistula Maturation Study.

Dember LM, Imrey PB, Duess MA, Hamburg NM, Larive B, Radeva M, Himmelfarb J, Kraiss LW, Kusek JW, Roy-Chaudhury P, Terry CM, Vazquez MA, Vongpatanasin W, Beck GJ, Vita JA; Hemodialysis Fistula Maturation Study GroupFeldmanH.FarberA.KaufmanJ.SternL.LeSageP.KivorkC.SoaresD.MalikovaM.AllonM.YoungC.TaylorM.WoodardL.MangadiK.MundaR.LeeT.AllowayR.El‐KhatibM.CanaanT.PflumA.ThiekenL.Campos‐NaciffB.HuberT.BerceliS.JansenM.McCaslinG.TrahanY.DavidsonI.HwangC.LightfootT.LivingstonC.ValenciaA.DolmatchB.FenvesA.HawkinsN.CheungA.KinikiniD.TreimanG.IhnatD.SarfatiM.LavasaniI.MaloneyM.SchlotfeldtL.BuchananC.ClarkC.CrawfordC.HamlettJ.KundzinsJ.ManahanL.WiseJ.GassmanJ.GreeneT.LiL.

J Am Heart Assoc. 2016 Jul 22;5(7). pii: e003227. doi: 10.1161/JAHA.116.003227.

47.

A wearable artificial kidney for patients with end-stage renal disease.

Gura V, Rivara MB, Bieber S, Munshi R, Smith NC, Linke L, Kundzins J, Beizai M, Ezon C, Kessler L, Himmelfarb J.

JCI Insight. 2016 Jun 2;1(8). pii: e86397.

48.

Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients.

Robinson-Cohen C, Katz R, Price BL, Harju-Baker S, Mikacenic C, Himmelfarb J, Liles WC, Wurfel MM.

Crit Care. 2016 Jul 3;20(1):207. doi: 10.1186/s13054-016-1385-3.

49.

Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study.

Afkarian M, Katz R, Bansal N, Correa A, Kestenbaum B, Himmelfarb J, de Boer IH, Young B.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1384-91. doi: 10.2215/CJN.13111215. Epub 2016 Jun 23.

50.

CKD and Muscle Mitochondrial Energetics.

Roshanravan B, Kestenbaum B, Gamboa J, Jubrias SA, Ayers E, Curtin L, Himmelfarb J, de Boer IH, Conley KE.

Am J Kidney Dis. 2016 Oct;68(4):658-659. doi: 10.1053/j.ajkd.2016.05.011. Epub 2016 Jun 14. No abstract available.

Supplemental Content

Loading ...
Support Center